Eli Lilly to Invest Over $1 Billion to Expand Manufacturing Footprint in India

Eli Lilly announced plans to invest more than $1 billion in India over the next several years to expand its manufacturing and supply capabilities, primarily through partnerships with local contract manufacturers234.

The investment aims to boost the production and availability of key Lilly drugs, including treatments for obesity, diabetes, Alzheimer’s, cancer, and autoimmune conditions256.

Lilly will establish a new Manufacturing & Quality hub in Hyderabad, enhancing oversight and technical capabilities for its contract manufacturing network in India4.

Recruitment for various roles—engineers, chemists, analytical scientists, quality professionals, and managers—will begin immediately in Hyderabad4.

Currently, Lilly does not operate its own manufacturing facility in India but is actively engaging with local contract manufacturers to scale up production2.

This expansion comes amid a broader trend of global drugmakers increasing U.S. manufacturing due to recent tariffs, but Lilly is simultaneously strengthening its presence in India as a strategic hub for global operations26.

Sources:

2. https://www.tradingview.com/news/reuters.com,2025:newsml_L3N3VM02U:0-eli-lilly-to-invest-over-1-billion-in-india-to-expand-manufacturing-capacity/

3. https://firstwordpharma.com/story/6314353

4. https://medicaldialogues.in/news/industry/pharma/eli-lilly-plans-to-invest-over-usd-1-billion-in-new-contract-manufacturing-in-india-156408

5. https://www.fiercepharma.com/manufacturing/eli-lilly-earmarks-over-1b-boost-contract-manufacturing-india

6. https://sbj.net/stories/eli-lilly-to-invest-over-1b-in-india-to-expand-manufacturing-capacity,101408